Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Toschi

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Annals of Internal Medicine|August 23, 2017
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized TrialRoy W Beck, Tonya D Riddlesworth, Katrina Ruedy, et al.
Nature Medicine|March 5, 2002
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcomaCecilia Sgadari, Giovanni Barillari, Elena Toschi, et al.
Frontiers in Endocrinology|December 6, 2021
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese WomenMegan Rodgers, Alexandra L Migdal, Tahereh Ghorbani Rodríguez, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Does Bovine Raw Milk Represent a Potential Risk for Vancomycin-Resistant Enterococci (VRE) Transmission to Humans?Elisa Massella, Simone Russo, Anita Filippi, et al.
Cancer Immunology Research|June 16, 2017
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic CellsAlessandra Fragale, Giulia Romagnoli, Valerio Licursi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 29, 2024
Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCTAndrew Healey, Tayana Soukup, Nick Sevdalis, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.
Diabetologia|March 24, 2022
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCTPeter Jacob, Laura Potts, Rory H Maclean, et al.
Nature Communications|April 28, 2022
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)Stephanie A Amiel, Laura Potts, Kimberley Goldsmith, et al.
Oncotarget|March 31, 2016
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancerMaria Buoncervello, Giulia Romagnoli, Mariachiara Buccarelli, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Annals of Internal Medicine|August 23, 2017
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized TrialRoy W Beck, Tonya D Riddlesworth, Katrina Ruedy, et al.
Nature Medicine|March 5, 2002
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcomaCecilia Sgadari, Giovanni Barillari, Elena Toschi, et al.
Frontiers in Endocrinology|December 6, 2021
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese WomenMegan Rodgers, Alexandra L Migdal, Tahereh Ghorbani Rodríguez, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Does Bovine Raw Milk Represent a Potential Risk for Vancomycin-Resistant Enterococci (VRE) Transmission to Humans?Elisa Massella, Simone Russo, Anita Filippi, et al.
Cancer Immunology Research|June 16, 2017
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic CellsAlessandra Fragale, Giulia Romagnoli, Valerio Licursi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 29, 2024
Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCTAndrew Healey, Tayana Soukup, Nick Sevdalis, et al.
The Lancet. Diabetes & Endocrinology|July 17, 2017
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trialRoy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, et al.
Diabetologia|March 24, 2022
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCTPeter Jacob, Laura Potts, Rory H Maclean, et al.
Nature Communications|April 28, 2022
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)Stephanie A Amiel, Laura Potts, Kimberley Goldsmith, et al.
Oncotarget|March 31, 2016
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancerMaria Buoncervello, Giulia Romagnoli, Mariachiara Buccarelli, et al.
Pageof 10